Business LineBusiness Line

Broker’s call: Ashok Leyland (Hold)

Thời gian đọc: dưới 1 phút

Target: ₹162

CMP: ₹167.80

Ashok Leyland (AL) reported an in-line 2QFY27 performance, with revenue growing 39.4 per cent y-o-y to ₹13,364 crore, exceeding estimates by 2.9 per cent, however, a 373 bps y-o-y contraction in gross margin offset the benefits of operating leverage, limiting EBITDA growth to 16.2 per cent to ₹1,350 crore (vs est of ₹1,340 crore) while EBITDA margin declined 202 bps to 10.1 % (vs. 10.3% estimated) and adjusted PAT grew 7.1 per cent to ₹870 crore (vs est of ₹900 crore).

The company’s domestic MHCV outperformance, traction in preimmunised products and expanding LCV presence indicate strengthening competitive positioning. Management’s expectation of mid-teen CV industry growth in FY27, supported by replacement demand, infrastructure activity and improving fleet economics, provides a favourable demand outlook.

While AL’s strong domestic market position and expanding non-core businesses provide structural support to its medium-term growth outlook, we believe the near-term risk-reward remains balanced, with margin pressures limiting earnings upside. A meaningful moderation in raw material costs remains the key potential earnings upgrade trigger, offering scope for a stronger-than-expected margin recovery and an improved earnings trajectory.

Following Q2-FY27 results, we have cut our FY27E/FY28E earnings estimates by 12.1/3.9 per cent, respectively, and retain our Hold rating with an unchanged SOTP-based target price of ₹162, valuing the standalone business at 12.5x FY28E EV/EBITDA and assigning ₹15/share to strategic investments.

Đọc toàn bộ bài viết
Mở khóa quyền truy cập không giới hạn vào các bài viết từ Business Line và mọi nguồn tin khác trên TradingView.